Norton Rose Fulbright Promotes 14 to Partner
Norton Rose Fulbright promoted 14 lawyers to partner in the United States. Among the promotions are Natasha Khan, Corporate, M&A and Securities; Bryon Farnsworth and Daniel Tristan, Finance; and Mark Faccenda, Healthcare Transactional.
Linda Addison, U.S. managing partner, Norton Rose Fulbright, said: “We are pleased to welcome this talented and driven group of partners. These lawyers have dedicated themselves to Norton Rose Fulbright and our clients. Each of them has valuable experience in their areas of practice as well as industry knowledge covering a wide range of sectors from energy to healthcare to financial institutions.”
Khan centers her practice on M&A, securities law and general corporate matters. Practicing in Houston, she has represented domestic and international clients in a variety of industries in connection with IPOs, public and private issuances of equity and debt securities, exchange offerings, joint ventures, mergers, acquisitions and dispositions. Khan received her JD from the Tulane University School of Law.
Farnsworth focuses on complex conduit bond representations and healthcare financings as bond counsel, underwriter’s counsel and borrower’s counsel. Working in Norton Rose Fulbright’s Denver office, he regularly works on a variety of transactions, including multistate healthcare system issuances, master trust indenture amendments and restructurings, interest rate exchange agreements, private placements and variable rate products. Farnsworth received his JD from Harvard Law School.
Tristan advises borrowers and financial institutions in connection with domestic and international financing transactions, including working capital credit facilities, asset-based financings, acquisition financings, project finance and commercial paper programs. Based in Houston, Tristan assists companies in securities law reporting and disclosure, corporate governance and hedging transactions. He earned his JD from the University of California at Berkeley School of Law.
Faccenda centers his practice on healthcare services matters, pharmaceutical and medical device disputes and clinical integration initiatives. He has represented healthcare industry clients on regulatory and transactional matters. Practicing in Washington, D.C., Faccenda’s clients include pharmaceutical manufacturers, academic medical centers, health systems and physician groups. He received his JD and MHA from the University of Pittsburgh School of Law.
To read the entire press release, click here.